Karl Cornelius

Karl Cornelius is an accomplished professional with extensive experience in the pharmaceutical industry, currently serving as Area Commercial Lead for Primary Care in Developed Asia at Pfizer since December 2015. In this role, Cornelius oversees the performance and local strategy execution for key brands, including Paxlovid(TM) and Comirnaty(TM), across Japan, South Korea, and ANZ. Prior to this position, Cornelius held various leadership roles within Pfizer and Hospira, focusing on strategic marketing, portfolio management, and launch initiatives, particularly in biologics, oncology, and hospital settings. Cornelius's educational background includes a Doctor of Philosophy in Physical Organic Chemistry and a Graduate Diploma in Intellectual Property from the University of Melbourne, complemented by a Bachelor of Science in Chemistry from the University of Adelaide.